Sahana N Kukke1, Carmen C Brewer, Christopher Zalewski, Kelly A King, Diane Damiano, Katharine E Alter, Mark Hallett. 1. *Human Motor Control Section, Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A.; †Functional and Applied Biomechanics Lab, Rehabilitation Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, U.S.A.; ‡Biomedical Engineering, The Catholic University of America, Washington, District of Columbia, U.S.A.; and §Audiology Unit, Otolaryngology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, U.S.A.
Abstract
PURPOSE: Concerns regarding hearing safety have limited the number of studies using transcranial magnetic stimulation (TMS) in children and young adults. The objective of this study was to examine the safety of TMS with regards to hearing in a group of 16 children and young adults (17.3 ± 4.9 years) with and without brain injury. METHODS: Pure-tone hearing thresholds and distortion-product otoacoustic emissions were measured before and after exposure to single- and paired-pulse TMS (1-2 sessions of 149-446 TMS pulses at a median of 49%-100% maximum stimulator output over a 2.2 hours period). RESULTS: No mean change in hearing outcomes was noted. In addition, no clinically significant change in hearing threshold was observed in any participant, and participants did not experience a subjective change in hearing after TMS exposure. CONCLUSIONS: Single- and double-pulse TMS administered within the parameters used in this study, which included hearing protection, can be used in children and young adults without impacting hearing. This study provides further evidence for hearing safety after TMS exposure in children and young adults.
PURPOSE: Concerns regarding hearing safety have limited the number of studies using transcranial magnetic stimulation (TMS) in children and young adults. The objective of this study was to examine the safety of TMS with regards to hearing in a group of 16 children and young adults (17.3 ± 4.9 years) with and without brain injury. METHODS: Pure-tone hearing thresholds and distortion-product otoacoustic emissions were measured before and after exposure to single- and paired-pulse TMS (1-2 sessions of 149-446 TMS pulses at a median of 49%-100% maximum stimulator output over a 2.2 hours period). RESULTS: No mean change in hearing outcomes was noted. In addition, no clinically significant change in hearing threshold was observed in any participant, and participants did not experience a subjective change in hearing after TMS exposure. CONCLUSIONS: Single- and double-pulse TMS administered within the parameters used in this study, which included hearing protection, can be used in children and young adults without impacting hearing. This study provides further evidence for hearing safety after TMS exposure in children and young adults.
Authors: A Pascual-Leone; L G Cohen; L I Shotland; N Dang; A Pikus; E M Wassermann; J P Brasil-Neto; J Valls-Solé; M Hallett Journal: Neurology Date: 1992-03 Impact factor: 9.910
Authors: Stefan M Goetz; Sarah H Lisanby; David L K Murphy; Rebecca J Price; Gwendolyn O'Grady; Angel V Peterchev Journal: Brain Stimul Date: 2014-10-23 Impact factor: 8.955
Authors: Sahana N Kukke; Ana Carolina de Campos; Diane Damiano; Katharine E Alter; Nicholas Patronas; Mark Hallett Journal: Clin Neurophysiol Date: 2014-11-15 Impact factor: 3.708
Authors: Philip G Janicak; David L Dunner; Scott T Aaronson; Linda L Carpenter; Terrence A Boyadjis; David G Brock; Ian A Cook; Karl Lanocha; Hugh B Solvason; Dafna Bonneh-Barkay; Mark A Demitrack Journal: CNS Spectr Date: 2013-07-30 Impact factor: 3.790
Authors: Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett Journal: Clin Neurophysiol Date: 2020-10-24 Impact factor: 4.861